Posts Categorized: Philadelphia Life Sciences Lab Space

Half of life sciences incubator space leased at B. Labs at Cira Centre

BriaCell Therapeutics Corp., a publicly-traded Canadian company, and Ceptur Therapeutics Inc., a New Jersey company developing gene-based medicines, are among those tenants leasing space at Brandywine Realty Trust’s B. Labs incubator at Cira Centre.  Half of the 50,000-square-foot incubator has been leased, according to the real estate company. Other tenants include: Leal Therapeutics, which is… Read more »

University of Pennsylvania commits $750M to STEM research, hiring and new facilities

The University of Pennsylvania will dedicate $750 million over the next five years to support medical and scientific research, with plans to add dozens of faculty members and launch several new capital projects on campus. Penn is concentrating the funding in novel therapeutics and health-related initiatives, energy and sustainability, data engineering and science, and infrastructure… Read more »

One uCity Square tops off, development team looks to next lab project

While the team topped off One uCity Square, a $280 million, 400,000-square-foot life sciences building, it has already turned its sights on designing another project to capture the robust demand for lab space in Philadelphia.  “We have an overflowing pipeline of tenants,” said John Grady, senior vice president at Wexford Science & Technology, which is building… Read more »

Iovance Biotherapeutics officially opens its $125M cell therapy center at the Philadelphia Navy Yard

Iovance Biotherapeutics Inc. formally marked the opening of its $125 million, 136,000-square-foot cell therapy center at the Philadelphia Navy Yard last week, just days after it successfully manufactured the first clinical batch of its experimental cell therapy targeting solid tumors at the facility. The company first announced in 2019 it would locate a new facility in Philadelphia,… Read more »

Berwyn real estate firm led by former BioMed exec forms $365M venture to buy up life sciences properties

Warren Avenue Investors, a Berwyn company established four years ago by a former BioMed Realty Trust Inc. executive, has formed a nearly $400 million joint venture with Ares Management Corp. to pursue buying life sciences real estate in emerging markets across the country. The partnership completed a $165 million recapitalization of five properties it owns—… Read more »

Center City office building hits the market in life sciences play

Stoltz Management, a Bala Cynwyd real estate company, has put up for sale 2300 Chestnut St., a Center City office building that could sell for an estimated $40 million.  Stoltz bought the 103,905-square-foot office building in 2017 for $28.75 million and invested in upgrades to the lobby and elsewhere. The building is 77% leased to… Read more »

Budd plant to be redeveloped as life sciences hub

An aging monument of Philadelphia’s industrial past is poised to become a harbinger of the city’s future as a life sciences hub. After 18 years of lying dormant, the Budd Co. Hunting Park plant, which at its prime employed some 7,000 workers who made parts for automobiles and trains, is undergoing a transformation into a… Read more »

Brandywine Realty Trust eyes Metroplex in Plymouth Meeting for new life sciences buildings

Brandywine Realty Trust plans to develop a site at its Metroplex Corporate Center off Chemical Road in Plymouth Meeting for life sciences research and manufacturing space. The Philadelphia real estate investment trust is seeking approvals for a single-story, 100,000-square-foot building that would be used for manufacturing and another 125,000-square-foot building that would be designed for… Read more »